Sight Sciences, Inc.
General ticker "SGHT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $177.7M (TTM average)
Sight Sciences, Inc. follows the US Stock Market performance with the rate: 49.2%.
Estimated limits based on current volatility of 3.0%: low 8.20$, high 8.71$
Factors to consider:
- Total employees count: 216 (+0.9%) as of 2024
- Top business risk factors: Third-party risks, Operational and conduct risks, Market competition, Cybersecurity threats, Dependence on product reimbursement
- Current price 43.7% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.23$, 5.80$]
- 2025-12-31 to 2026-12-31 estimated range: [2.32$, 5.88$]
Financial Metrics affecting the SGHT estimates:
- Positive: with PPE of -3.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.64 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: 41.86 < Shareholder equity ratio, % of 61.27 <= 63.39
- Positive: Investing cash flow per share per price, % of -0.22 > -0.66
- Positive: Interest expense per share per price, % of 2.64 <= 3.41
- Negative: negative Net income
- Positive: Inventory ratio change, % of -1.49 <= -0.75
Short-term SGHT quotes
Long-term SGHT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $71.33MM | $81.06MM | $79.87MM |
| Operating Expenses | $155.28MM | $138.33MM | $130.40MM |
| Operating Income | $-83.95MM | $-57.27MM | $-50.53MM |
| Non-Operating Income | $-2.24MM | $1.84MM | $-0.74MM |
| Interest Expense | $4.47MM | $5.41MM | $4.66MM |
| R&D Expense | $22.86MM | $17.56MM | $17.99MM |
| Income(Loss) | $-86.19MM | $-55.44MM | $-51.27MM |
| Taxes | $0.05MM | $0.11MM | $0.24MM |
| Profit(Loss)* | $-86.24MM | $-55.55MM | $-51.51MM |
| Stockholders Equity | $160.08MM | $120.22MM | $87.52MM |
| Inventory | $6.11MM | $7.85MM | $6.33MM |
| Assets | $213.07MM | $166.65MM | $142.84MM |
| Operating Cash Flow | $-75.97MM | $-47.18MM | $-22.35MM |
| Capital expenditure | $0.97MM | $0.79MM | $0.39MM |
| Investing Cash Flow | $-0.97MM | $-0.79MM | $-0.39MM |
| Financing Cash Flow | $1.25MM | $1.10MM | $4.96MM |
| Earnings Per Share** | $-1.80 | $-1.14 | $-1.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.